Posttransplantation lymphoproliferative disorder in cardiac transplant allografts
- PMID: 9436585
- DOI: 10.1016/s0003-4975(97)01044-8
Posttransplantation lymphoproliferative disorder in cardiac transplant allografts
Abstract
Posttransplantation lymphoproliferative disorder occurs in 1.5% to 13% of heart transplant recipients and rarely involves the allograft. We report a case of posttransplantation lymphoproliferative disorder restricted to the mitral valve in a heart transplant recipient. Thirteen cases of cardiac allograft involvement by posttransplantation lymphoproliferative disorder are reported in the literature. None are restricted to the allograft. Five specify sites of cardiac involvement. Valvular masses without infection necessitate evaluation for posttransplantation lymphoproliferative disorder involvement of the cardiac allograft valve.
Similar articles
-
Diagnosis of posttransplantation lymphoproliferative disorder by endomyocardial biopsy in a cardiac allograft recipient.J Heart Lung Transplant. 1994 Mar-Apr;13(2):241-5. J Heart Lung Transplant. 1994. PMID: 8031806
-
Lymphoproliferative disease seen as a cardiac mass after orthotopic heart transplantation.J Am Soc Echocardiogr. 1998 Jul;11(7):758-60. doi: 10.1053/je.1998.v11.a90473. J Am Soc Echocardiogr. 1998. PMID: 9692534
-
Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.Exp Clin Transplant. 2011 Aug;9(4):258-64. Exp Clin Transplant. 2011. PMID: 21819371 Review.
-
CT of posttransplantation lymphoproliferative disorder in pediatric recipients of lung allograft.AJR Am J Roentgenol. 2003 Oct;181(4):1125-31. doi: 10.2214/ajr.181.4.1811125. AJR Am J Roentgenol. 2003. PMID: 14500243
-
Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation.Intern Med J. 2015 May;45(5):583-6. doi: 10.1111/imj.12735. Intern Med J. 2015. PMID: 25955465 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical